ID
ELV icon

Integral Derivatives’s Elevance Health ELV Stock Holding History

Integral Derivatives’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$593K Buy
+2,700
New +$634K 0.01% 349
2017
Q3 		– Sell
-24,700
Closed -$4.65M – 1174
2017
Q2 		$4.65M Buy
24,700
+16,200
+191% +$2.91M 0.1% 120
2017
Q1 		$1.41M Buy
+8,500
New +$1.35M 0.03% 417
2014
Q4 		– Sell
-28,100
Closed -$3.36M – 1413
2014
Q3 		$3.36M Sell
28,100
-4,000
-12% -$459K 0.06% 295
2014
Q2 		$3.45M Buy
+32,100
New +$3.31M 0.06% 260

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Integral Derivatives's ELV Position: Q1 2018 in Review

Integral Derivatives sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 8,620 shares — an estimated $2.02M sold.

Integral Derivatives first reported a position in ELV in Q3 2015 and held it in 3 quarters. The position peaked at $1.94M in Q4 2017. 922 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

  • Integral Derivatives reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
  • Integral Derivatives sold 8,620 Elevance Health shares in Q1 2018, an estimated $2.02M.
  • Integral Derivatives first reported a position in Elevance Health in Q3 2015 and held it in 3 quarters.
  • Integral Derivatives's Elevance Health position peaked at $1.94M in Q4 2017.
  • 922 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.